Nicole L Levidow

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
As lower-cost versions of original biologic drugs made by different manufacturers, follow-on biologics offer the promise of meaningful savings for the US health care system and improved patient health outcomes through greater medication adherence. Fulfillment of this promise, however, is predicated on the prescribing of such products. Under state drug(More)
  • 1